Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma
Status:
Not yet recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the effect of traditional Chinese medicine Babaodan on
tumor recurrence of hepatocellular carcinoma after curative resection, as well as the safety
of this treatment
Phase:
Phase 4
Details
Lead Sponsor:
Eastern Hepatobiliary Surgery Hospital
Collaborators:
First Affiliated Hospital, Sun Yat-Sen University Fujian Mengchao Hepatobiliary Hospital Second Military Medical University Shanghai Zhongshan Hospital Sun Yat-sen University The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Xiamen Traditional Chinese Medicine Co., Ltd.